SUVN-K-1806045 demonstrates analgesia in models of nociception and diabetic neuropathic pain Oct. 28, 2019 No Comments
New glutamate receptor modulator DT-095435 shows impressive in vivo antiparkinsonian potential Oct. 25, 2019 No Comments
SUVN-1702012 for psychiatric disorders balancing antipsychotic and motor side effects Oct. 25, 2019 No Comments
Muscarinic M1 receptor antagonist PIPE-359 shows promising in vivo results for the treatment of MS Oct. 24, 2019 No Comments
VBJ-192 and VBJ-215 show encouraging results without tolerance or locomotor side effects Oct. 23, 2019 No Comments
University Hospital Heidelberg describes clinical testing of 18F-labeled FAPI tracer Oct. 21, 2019 No Comments
Improved PSMA-targeting radiotherapeutic agents developed for prostate cancer Oct. 21, 2019 No Comments